Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kudva

Showing results (31-40 of 246) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|October 20, 2001
Thalidomide for malignant melanomaG C Kudva, B T Collins, F R Dunphy
Mayo Clinic Proceedings|May 3, 2023
Time in Range Goal is Achieved in a Unique WayShafaq R Rizvi, Ravinder J Kaur, Yogish C Kudva
BMJ Open Diabetes Research & Care|March 23, 2019
Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetesAnupam Kotwal, Candace Haddox, Matthew Block, et al.
Mayo Clinic Proceedings|January 5, 2023
46-Year-Old Woman With Type 2 Diabetes Mellitus and ObesityJohn D Christensen, Jacob D Kohlenberg, Yogish C Kudva
American Journal of Hematology|February 24, 2006
RhD alloimmunization without apparent exposure to RhD antigenGanesh C Kudva, Kent D Branson, Brenda J Grossman
Bone Marrow Transplantation|November 21, 2007
Heparin toxicity following allogeneic bone marrow infusionM J Williamson, G C Kudva, S M Pincus
Diabetes Care|March 29, 2005
Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patientsBryan J Krajicek, Yogish C Kudva, Heather A Hurley
Endocrine Reviews|May 14, 2019
Diabetic GastroparesisAdil E Bharucha, Yogish C Kudva, David O Prichard
Diabetes Technology & Therapeutics|May 10, 2014
Exercise, hypoglycemia, and type 1 diabetesRita Basu, Matthew L Johnson, Yogish C Kudva, et al.
Current Diabetes Reports|August 31, 2018
Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 DiabetesVikash Dadlani, Jordan E Pinsker, Eyal Dassau, et al.
Pageof 25

Showing results (31-40 of 246) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|October 20, 2001
Thalidomide for malignant melanomaG C Kudva, B T Collins, F R Dunphy
Mayo Clinic Proceedings|May 3, 2023
Time in Range Goal is Achieved in a Unique WayShafaq R Rizvi, Ravinder J Kaur, Yogish C Kudva
BMJ Open Diabetes Research & Care|March 23, 2019
Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetesAnupam Kotwal, Candace Haddox, Matthew Block, et al.
Mayo Clinic Proceedings|January 5, 2023
46-Year-Old Woman With Type 2 Diabetes Mellitus and ObesityJohn D Christensen, Jacob D Kohlenberg, Yogish C Kudva
American Journal of Hematology|February 24, 2006
RhD alloimmunization without apparent exposure to RhD antigenGanesh C Kudva, Kent D Branson, Brenda J Grossman
Bone Marrow Transplantation|November 21, 2007
Heparin toxicity following allogeneic bone marrow infusionM J Williamson, G C Kudva, S M Pincus
Diabetes Care|March 29, 2005
Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patientsBryan J Krajicek, Yogish C Kudva, Heather A Hurley
Endocrine Reviews|May 14, 2019
Diabetic GastroparesisAdil E Bharucha, Yogish C Kudva, David O Prichard
Diabetes Technology & Therapeutics|May 10, 2014
Exercise, hypoglycemia, and type 1 diabetesRita Basu, Matthew L Johnson, Yogish C Kudva, et al.
Current Diabetes Reports|August 31, 2018
Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 DiabetesVikash Dadlani, Jordan E Pinsker, Eyal Dassau, et al.
Pageof 25